In North America, key drivers include established healthcare infrastructure, high research activity, and stringent regulatory policies. In Europe, mature ecosystem, high investments in research and development, and adoption of advanced technologies are expected to drive the market. In Asia Pacific, large patient population, increasing healthcare expenditure, and government initiatives are expected to contribute to the market growth. In Latin America, growing middle-class population, expanding pharmaceutical industry, and increasing adoption of doxycycline monohydrate reagent are expected to drive the market. In Middle East & Africa, rising healthcare expenditure, increasing research activities, and government initiatives are expected to contribute to the regional forecast.